Time course of biochemical and behavioural effects of a single high dose of chlorpyrifos

NeuroToxicology

Volumn 28, Issue 3, 2007, Pages 541-547

  Lopez Crespo G A ^a   Carvajal, F ^a   Flores, P ^a   Sanchez Santed F ^a   Sanchez Amate M C ^a  

^a UNIVERSITY OF ALMERÍA   (Spain)

Author keywords

Amphetamine; Anxiety; Chlorpyrifos; Locomotor activity; Open field; Tolerance

Indexed keywords

ACETYLCHOLINESTERASE; AMPHETAMINE; CHLORPYRIFOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INHIBITION; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TRANQUILIZING ACTIVITY;

ACETYLCHOLINESTERASE; AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; DATA INTERPRETATION, STATISTICAL; DIARRHEA; EMOTIONS; INSECTICIDES; MALE; MOTOR ACTIVITY; PILOERECTION; RATS; RATS, WISTAR; SALIVATION; STRESS, PSYCHOLOGICAL; TEARS;

RATTUS;

EID: 34249855869     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2007.01.013     Document Type: Article

References (35)

1. Abou-Donia M.B. Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health 58 (2003) 484-497
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
3. Brown M.A., and Brix K.A. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 18 (1998) 393-408
4. Bushnell P.J., Padilla S.S., Ward T., Pope C.N., and Olszyk V.B. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropyflluorophosphate. J Pharmacol Exp Ther 256 (1991) 741-750
5. Bushnell P.J., Pope C.N., and Padilla S. Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibitionof cholinesterase. J Pharmacol Exp Ther 266 (1993) 1007-1017
6. Bushnell P.J., Kelly K.L., and Ward T.R. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance. J Pharmacol Exp Ther 270 (1994) 15-25
7. Cañadas F., Cardona D., Dávila E., and Sánchez-Santed F. Long-term neurotoxicity of chlorpyrifos: spatial learning impairment on repeated acquisition in a water maze. Toxicol Sci 85 (2005) 944-951
8. Cheeta S., Kenny P.J., and File S.E. Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal ttests of anxiety. Prog. Neuro-Psychopharmacol Biol. Psychiatry 24 (2000) 1053-1067
9. Choleris E., Thomas A.W., Kavaliers M., and Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 25 (2001) 235-260
10. Dam K., Seidler F.J., and Slotkin T.A. Chlorpyrifos releases norepinephrine from adult and neonatal rat brain synaptosomes. Dev Brain Res 118 (1999) 129-133
11. Ellman G.L., Courtney K.D., Andres V.J., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7 (1961) 88-95
12. File S.E., Kenny P.J., and Cheeta S. The role of the dorsal hippocampal serotoninergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 66 (2000) 65-72
13. Gordon C.J., and Grantham T.A. Effect of central and peripheral cholinergic antagonists on chlorpyrifos-induced changes in body temperature in the rat. Toxicology 142 (1999) 15-28
14. Gralewicz S., Lutz P., and Tomas T. Behavioural responsiveness to amphetamine or scopolamine following repeated exposure to chlorphenvinphos in rats. Acta Neurobiol Exp 62 (2002) 75-83
15. Gupta R.L. Brain regional heterogeneity and toxicological mechanism of organophosphates and carbamates. Toxicol Mech Meth 14 (2004) 103-143
16. Jamal G.A. Neurological syndromes of organophosphorus compounds. Adv Drug React Toxicol Rev 16 (1997) 133-170
17. 3H]hemicolinium-3 binding in rat brain. Fundam Appl Toxicol 34 (1996) 84-90
18. Liu J., and Pope C.N. Comparative presynaptic neurochemical changes in rat striatum following exposure to chlorpyrifos or parathion. J Toxicol Environ Health, A 53 (1998) 531-544
19. Lotti M. Cholinesterase inhibition: complexities in interpretation. Clin Chem 41 (1995) 1814-1818
20. Lutz P., Tomas T., Gralewicz S., and Nowakowska E. Long-term effects of acute exposure to chlorphenvinphos on behavioural responsiveness to amphetamine and scopolamine in rats. Int J Occup Med Environ Health 13 (2000) 215-222
21. Lutz P., Tomas T., Gralewicz S., Kur B., and Wiaderna D. Amphetamine- and scopolamine-induced locomotor activity following treatment with cholphenvinphos or cholorpyrifos in rats. Int J Occup Med Environ Health 18 (2005) 115-125
22. Mattson A., Ögren S.O., and Olson L. Facilitation of dopamine mediated locomotor activity in adult rats following cholinergic denervation. Exp Neurol 174 (2002) 96-108
23. Moser V.C. Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats. Neurotoxicol Teratol 17 (1995) 617-625
24. Nakamura K., and Kurasawa M. Anxiolytic effects of amiracetam in three different mouse models of anxiety and the underlying mechanism. Eur J Neurosci 420 (2001) 33-43
25. Overstreet D.H., Miller C.S., Janowsky D.S., and Russell R.W. Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity. Toxicology 111 (1996) 119-134
26. Pope C.N., Chakraborti T.K., Chapman M.L., and Farrar J.D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphrothioate insecticides. Toxicology 68 (1991) 51-61
27. Pope C.N., Chakraborti T.K., Chapman M.L., and Farrar J.D. Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol Biochem Behav 42 (1992) 251-256
28. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463 (2003) 3-33
29. Reiter L.W., and MacPhail R.C. Factors influencing motor activity measurements in neurotoxicology. In: Mitchell C.L. (Ed). Nerv Syst Toxicol (1982), Raven Press, New York 45-65
30. Richardson R.J. Assessment of the neurotoxic potential of chlorpyrifos relative ot other organophosphorus compounds: a critical review of the literature. J Toxicol Environ Health 44 (1995) 135-165
31. Sánchez-Amate M.C., Flores P., and Sánchez-Santed F. Effects of chlorpyrifos in the plus-maze model of anxiety. Behav Pharmacol 12 (2001) 285-292
32. Sánchez-Amate M.C., Dávila E., Cañadas F., Flores P., and Sánchez-Santed F. Chlorpyrifos shares stimulus properties with pentilenetetrazol as evaluated by and operant drug discrimination task. Neurotoxicology 23 (2002) 795-803
33. Sánchez-Santed F., Cañadas F., Flores P., López-Grancha M., and Cardona D. Long-term functional neurotoxicity of paraoxon and chlorpyrifos: behavioural and pharmacological evidence. Neurotoxicol Teratol 26 (2004) 305-317
34. Sienkiewicz-Jarosz H., Czlonkowska A.I., Siemiatkowski M., Maciejak P., Szyndler J., and Plaznik A. The effects of physiostigmine and cholinergic receptor ligands on novelty-induced neophobia. J Neural Transm 107 (2000) 1403-1412
35. Treit D., and Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 31 (1989) 959-962